Treatment Hypertension to Recommended Levels in Old Patients

Launched by I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY · Mar 4, 2025

Keywords

ClinConnect Summary

The study duration is 3 months. It is planned to include at least 60 patients in the study. Before any procedures related to the study, the patient must be provided with comprehensive information about the study product, possible risks associated with its use and / or participation in the study. The study participant must provide written consent to participate in the study. At the first face-to-face visit, informed voluntary consent will be obtained in both groups, a physical examination will be performed, including measuring blood pressure, heart rate, and an orthostatic test. Monitoring w...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Men and women aged 65 years and older with hypertension previously diagnosed based on repeated measurements in a medical institution.
• Exclusion Criteria:
• • 1. Diagnosed dementia or severe cognitive impairment.
• • 2. Inability to fill in questionnaires specified in the study protocol.
• • 3. Inability to use automatic devices for recording blood pressure at home.
• • 4. Inability to use electronic devices required for remote monitoring of home blood pressure measurements and patient well-being.
• • 5. Presence of hemodynamically significant valvular heart defects.
• • 6. Presence of severe renal impairment (eGFR \<30 ml/min/1.73 m2) and/or increased blood creatinine levels to 221 μmol
• • 7. Myocardial infarction or stroke within the previous 6 months.
• • 8. Chronic heart failure with EF ≤ 40%.